HUM on NYSE

Humana

Logo: Humana, Public domain, via Wikimedia Commons6

American health insurance company based in Louisville, Kentucky

Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list. It is the fourth largest health insurance provider in the U.S.3 It was founded by Wendell Cherry.1 Its chief executive is Bruce Broussard.1 It employed about 51,600 people in 2016.1 Its revenue was $92.9 billion in 2022.1 Wikipedia text CC BY-SA 4.0

$412.88 down 19.32 (4.47%)Price as of Oct 16, 2026 at 19:58 UTC

Last updated Oct 21, 2026.

Overview

1961Founded1

Compare with Centene Corporation, Elevance Health, Inc. or The Cigna Group, or pick any stock.

  • TickerHUM on NYSE1
  • Industryinsurance industry1
  • HeadquartersLouisville1
  • Websitewww.humana.com
  • Legal formDelaware corporation1
  • Incorporated inDE7
  • Business address101 E. Main Street, Louisville, Ky7
  • Filer categoryLarge accelerated filer7
  • LEI529900YLDW34GJAO4J064
  • StatusActive4
  • LEI statusIssued and current4
  • Registered addressC/O THE CORPORATION TRUST COMPANY, 19801 Wilmington, United States4
  • Registered withDivision of Corporations, Department of State, 6137124

Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list. It is the fourth largest health insurance provider in the U.S.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

2.1%Operating margin10
0.9%Net margin10
10.1%Revenue growth, 202510
6.7%Return on equity10
0.70×Debt to equity10
$375.0MFree cash flow10

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

External Revenues brought in 96% of the revenue Humana broke down this way in fiscal 2025.

  1. External Revenues$128.7B1096%up 10% from 2024
  2. Service$5.8B104%up 32% from 2024
Products and services by year
Products and services202320242025
External Revenues$105.3B$116.5B$128.7B
Service$4.0B$4.4B$5.8B

Business segments

Insurance brought in 85% of the revenue Humana broke down this way in fiscal 2025.

  1. Insurance$124.6B1085%up 9% from 2024
  2. CenterWell$22.5B1015%up 13% from 2024
Business segments by year
Business segments202320242025
Insurance$102.9B$113.8B$124.6B
CenterWell$18.4B$19.9B$22.5B

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Selling, general and admin12¢$15.4B
  • Other costs87¢$112.8B
  • Income tax0¢$250.0M
  • Profit1¢$1.2B

Out of $129.7B in revenue.10

Where each dollar of operating cash went, fiscal 2025

  • Capital spending48¢$546.0M
  • Dividends paid38¢$430.0M
  • Share buybacks13¢$151.0M

Out of $921.0M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.10

Financial statements

Revenue1112131410$129.7B in 2025+100% since 2019
0$50.0B$100.0B$150.0B2019: $64.9B$64.9B20192020: $77.2B$77.2B2020+19%2021: $83.1B$83.1B2021+8%2022: $92.9B$92.9B2022+12%2023: $106.4B$106.4B2023+15%2024: $117.8B$117.8B2024+11%2025: $129.7B$129.7B2025+10%
Operating income1112131410$2.7B in 2025−15% since 2019
0$2.0B$4.0B$6.0B2019: $3.2B$3.2B20192020: $5.0B$5.0B2020+56%2021: $3.1B$3.1B2021−37%2022: $3.8B$3.8B2022+21%2023: $4.0B$4.0B2023+6%2024: $2.6B$2.6B2024−36%2025: $2.7B$2.7B2025+6%
Net income1112131410$1.2B in 2025−56% since 2019
0$1.0B$2.0B$3.0B$4.0B2019: $2.7B$2.7B20192020: $3.4B$3.4B2020+24%2021: $2.9B$2.9B2021−13%2022: $2.8B$2.8B2022−4%2023: $2.5B$2.5B2023−11%2024: $1.2B$1.2B2024−52%2025: $1.2B$1.2B2025−2%

Every line of the income statement as filed: the last 3 fiscal years, latest first.10

Period ending2025-12-312024-12-312023-12-31
Premiums$122.8B$112.1B$101.3B
Services$5.8B$4.4B$4.0B
Investment income$1.0B$1.2B$1.1B
Total revenues$129.7B$117.8B$106.4B
Benefits$110.8B$100.7B$88.4B
Operating costs$15.4B$13.7B$13.2B
Depreciation and amortization$698.0M$839.0M$779.0M
Total operating expenses$127.0B$115.2B$102.4B
Income (loss) from operations$2.7B$2.6B$4.0B
Loss on sale of business$67.0M$0$0
Interest expense$631.0M$660.0M$493.0M
Other expense, net$451.0M$181.0M$137.0M
Income before income taxes and equity in net losses$1.6B$1.7B$3.4B
Provision for income taxes$250.0M$413.0M$836.0M
Equity in net losses-$102.0M-$94.0M-$63.0M
Net income$1.2B$1.2B$2.5B
Net (income) loss attributable to noncontrolling interests-$15.0M-$7.0M$5.0M
Net income attributable to Humana$1.2B$1.2B$2.5B
Basic earnings per common share (in dollars per share)$9.87$10.01$20.09
Diluted earnings per common share (in dollars per share)$9.84$9.98$20.00

Compare Humana with another company

Corporate structure

Humana sits at the top of its group. 35 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Humana

  • &. Cox Dodge Filed SCHEDULE 13G/A on Humana, latest May 14, 2026 (2 filings since Feb 13, 2025)
  • VANGUARD CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G on Humana, latest Apr 30, 2026
  • VANGUARD GROUP INC Filed SCHEDULE 13G/A on Humana, latest Mar 27, 2026 (6 filings since Feb 10, 2022)
  • BlackRock Filed SCHEDULE 13G/A on Humana, latest Apr 17, 2025 (5 filings since Feb 1, 2022)
  • PRICE T ROWE ASSOCIATES INC /MD/ Filed SC 13G/A on Humana, latest Feb 16, 2024 (4 filings since Feb 14, 2022)
  • FMR LLC Filed SC 13G/A on Humana, latest Feb 9, 2024 (3 filings since Feb 9, 2022)
  • Wellington Management Company Filed SC 13G/A on Humana, latest Feb 8, 2024 (2 filings since Feb 6, 2023)
  • Humana Louisville, Kentucky, United States
    • Oak Street Health, Inc. Stake · Chicago, Illinois, United States
    • Access Home Health of Subsidiary · Florida, United States
    • Arcadian Health Plan, Inc. Subsidiary · Louisville, Kentucky, United States
    • Capital Care Resources of Subsidiary · South Carolina, United States
    • CHA HMO, Inc. Subsidiary · Louisville, Kentucky, United States
    • Conviva Health MSO of Subsidiary · Texas, United States
    • EMPHESYS INSURANCE COMPANY Subsidiary · Louisville, Kentucky, United States
    • Healthfield of Subsidiary · Tennessee, United States
    • Healthfield of Southwest Subsidiary · Georgia, United States
    • Home Health Care Affiliates of Subsidiary · Mississippi, United States
    • Home Health Care Affiliates of Central Subsidiary · Mississippi, United States
    • Home Health of Rural Subsidiary · Texas, United States
    • Humana Benefit Plan of Subsidiary · Illinois, United States
    • HUMANA BENEFIT PLAN OF ILLINOIS, INC. Subsidiary · Louisville, Kentucky, United States
    • Humana Employers Health Plan of Subsidiary · Georgia, United States
    • Humana Health Benefit Plan of Subsidiary · Louisiana, United States
    • HUMANA HEALTH BENEFIT PLAN OF LOUISIANA, INC. Subsidiary · Louisville, Kentucky, United States
    • Humana Health Company of Subsidiary · New York, United States
    • Humana Health Insurance Company of Subsidiary · Florida, United States
    • Humana Health Plan of Subsidiary · California, United States
    • Humana Health Plan, Inc. Subsidiary · Louisville, Kentucky, United States
    • Humana Health Plans of Subsidiary · Puerto Rico, United States
    • HUMANA INSURANCE COMPANY Subsidiary · Depere, Wisconsin, United States
    • Humana Insurance Company of Subsidiary · Kentucky, United States
    • Humana Life Insurance Company of Subsidiary · New York, United States
    • and 9 more

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

What it owns

What Humana reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$5.5B10 Dec 31, 2025$5.7B10 Dec 31, 2024−2.7%
Accumulated depreciation$3.3B10 Dec 31, 2025$3.1B10 Dec 31, 2024+4.7%
Property and equipment, net$2.2B10 Dec 31, 2025$2.5B10 Dec 31, 2024−11.9%
Operating-lease assets (leased space)$485.0M10 Dec 31, 2025$445.0M10 Dec 31, 2024+9.0%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$4.2B10 Dec 31, 2025$2.2B10 Dec 31, 2024+89.1%
Marketable securities, current$15.7B10 Dec 31, 2025$18.2B10 Dec 31, 2024−13.8%
Marketable securities, non-current$493.0M10 Dec 31, 2025$421.0M10 Dec 31, 2024+17.1%
Debt securities available for sale$16.2B10 Dec 31, 2025$18.6B10 Dec 31, 2024−13.1%
Stakes in other companies (equity method)$638.0M10 Dec 31, 2025$697.0M10 Dec 31, 2024−8.5%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$9.7B10 Dec 31, 2025$9.6B10 Dec 31, 2024+0.6%
Intangible assets, net (excluding goodwill)$1.1B10 Dec 31, 2025$1.4B10 Dec 31, 2024−21.8%
Accumulated amortization$912.0M10 Dec 31, 2025$993.0M10 Dec 31, 2024−8.2%

Properties, in its own words

Our principal executive office is located in the Humana Building, 101 East Main Street, Louisville, Kentucky 40202. In addition to the headquarters in Louisville, Kentucky, we maintain other principal operating facilities used for customer service, enrollment, and/or claims processing and certain other corporate functions. Our key administrative functions are located in Louisville, Kentucky; Arlington, Virginia; and Green Bay, Wisconsin. We also have regional administrative support offices in Arizona, Florida, Georgia, Illinois, Massachusetts, New York, Tennessee and Texas.

We owned or leased numerous medical centers and administrative offices at December 31, 2025. The medical centers we operate are primarily located in Florida and Texas, including full-service, multi-specialty medical centers staffed by primary care providers and medical specialists. Of these medical centers, approximately 372 of these facilities are leased or subleased to our contracted providers to operate.

Item 2 of the 10-K filed Feb 19, 2026.19

The story

Founded by Wendell Cherry in 1961.1

1961–1983: Nursing homes and hospitals

Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).

In 1974, the partners changed the corporate name to Humana Inc. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s.

1984–present

As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."

In 1993, Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.

In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value.

In 2010, Humana returned to providing healthcare services when it bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million. They went on to sell Concentra again in 2015 for $1 billion.

In July 2015, Aetna announced that it would acquire Humana for $37 billion. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna and Humana cancelled a $34 billion merger agreement after judges ruled against the merger for a second time.

In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million.

Read the full text

In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO.

In 2024 Humana announced that they would be leaving the Humana Building, which they had occupied since the 1980s, in order to cut costs. Humana said that it planned to consolidate its workforce in its Waterside-Clocktower campus.

In 2026 KFF reported that Humana was the second-largest parent organization for Medicare Advantage by overall enrollment, and that it had the largest growth in that sector that year.

From Wikipedia’s article on Humana, shared under CC BY-SA 4.0.8

Leadership

Who has led Humana, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (64)

Products and brands

In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.

In 2009, HMHS' contract with the military was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.

From Wikipedia’s article on Humana, shared under CC BY-SA 4.0.8

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • Access Home Health of Florida, LLC9
  • Capital Care Resources of South Carolina, LLC9
  • Conviva Health MSO of Texas, Inc.9
  • Healthfield of Tennessee, LLC9
  • Healthfield of Southwest Georgia, LLC9
  • Home Health Care Affiliates of Mississippi, Inc.9
  • Home Health Care Affiliates of Central Mississippi, L.L.C.9
  • Home Health of Rural Texas, Inc.9
  • Humana Benefit Plan of Illinois, Inc.9
  • Humana Employers Health Plan of Georgia, Inc.9
  • Humana Health Benefit Plan of Louisiana, Inc.9
  • Humana Health Company of New York, Inc.9
  • Humana Health Insurance Company of Florida, Inc.9
  • Humana Health Plan of California, Inc.9
  • Humana Health Plans of Puerto Rico, Inc.9
  • Humana Insurance Company of Kentucky9
  • Humana Insurance of Puerto Rico, Inc.9
  • Humana Life Insurance Company of New York, Inc.9
  • Humana Management Services of Puerto Rico, Inc.9
  • Humana MarketPOINT of Puerto Rico, Inc.9
  • Humana Medical Plan of Michigan, Inc.9
  • Integracare of Texas, LLC9
  • METCARE of Florida, Inc.9
  • Med. Tech. Services of South Florida, Inc.9
All 26 listed subsidiaries
  • Outreach Health Services of North Texas, LLC9
  • Total Care Home Health of North Carolina, LLC9

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Employees over time

  • 201651,6001

Timeline

  1. Oct 13, 20268-K Regulation FD disclosure106
  2. Oct 9, 20268-K Regulation FD disclosure107
  3. Sep 1, 20268-K Regulation FD disclosure108
  4. Jul 29, 20268-K Results of operations; Regulation FD disclosure109
  5. Jul 29, 20268-K Executive or director change110
  6. Jun 1, 20268-K Regulation FD disclosure111
  7. May 19, 20268-K Entered a material agreement; New debt or obligation112
  8. Apr 29, 20268-K Results of operations; Regulation FD disclosure113
  9. Apr 20, 20268-K Shareholder vote114
  10. Apr 10, 20268-K Executive or director change115
  11. Mar 9, 20268-K Entered a material agreement; New debt or obligation; Other events116
  12. Mar 2, 20268-K Regulation FD disclosure117
  13. Dec 17, 2024New chief executive James A. Rechtin becomes CEO20
  14. Feb 20, 2014New chief executive Bruce Broussard becomes CEO1
  15. Aug 11, 2003New chief executive Michael McCallister becomes CEO22
  16. 1961Founded Founded1

Calendar

Coming up

  1. Nov 6, 2026 · Before the openReports results for the quarter ending Sep/2026 A year earlier it reported $3.24 a share, on Nov 5, 2025.118

When it reported results

  1. Jul 29, 2026Reported quarterly or annual results109
  2. Apr 29, 2026Reported quarterly or annual results113
  3. Feb 11, 2026Reported quarterly or annual results119
  4. Nov 5, 2025Reported quarterly or annual results120
  5. Jul 30, 2025Reported quarterly or annual results121
  6. Apr 30, 2025Reported quarterly or annual results122
  7. Feb 11, 2025Reported quarterly or annual results123
  8. Oct 30, 2024Reported quarterly or annual results124

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

526 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 88 major events, 309 insider forms, 23 large holders, 86 other. The latest 20:

  1. Oct 13, 20268-K EDGAR
  2. Oct 9, 20268-K EDGAR
  3. Oct 2, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  4. Sep 3, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  5. Sep 1, 20268-K EDGAR
  6. Aug 31, 20263 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  7. Aug 4, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  8. Aug 4, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  9. Jul 29, 20263 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  10. Jul 29, 20263 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  11. Jul 29, 202610-Q EDGAR
  12. Jul 29, 20268-K EDGAR
  13. Jul 29, 20268-K EDGAR
  14. Jul 2, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  15. Jun 24, 202611-K EDGAR
  16. Jun 24, 202611-K EDGAR
  17. Jun 1, 20268-K EDGAR
  18. May 19, 20268-K EDGAR
  19. May 14, 2026SCHEDULE 13G/A EDGAR
  20. May 5, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR

The 526 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

23 open-market trades by officers, directors and large owners since October 2021: 3 buys and 20 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Feb 23, 2026Shetty Sanjay KPresident, CenterWellBuy810$185.21$150.0KForm 4
May 14, 2025Rechtin James A.President & CEOBuy6,530$229.25$1.5MForm 4
Dec 31, 2024Huval Timothy S.Chief Administrative OfficerSale3,703$256.26$948.9KForm 4
Feb 20, 2024Mesquita Jorge S.DirectorBuy545$367.09$200.1KForm 4
May 4, 2023Diamond Susan MChief Financial OfficerSale4,156$526.28$2.2MForm 4
Feb 27, 2023BROUSSARD BRUCE DChief Executive OfficerSale17,575$505.85$8.9MForm 4
Feb 27, 2023Ventura Joseph CChief Legal OfficerSale2,048$507.97$1.0MForm 4
Feb 27, 2023Huval Timothy S.Chief Administrative OfficerSale2,628$510.30$1.3MForm 4
Dec 21, 2022JONES DAVID A JR/KYDirectorSale15,000$501.72$7.5MForm 4
Dec 16, 2022Huval Timothy S.Chief Administrative OfficerSale635$497.71$316.0KForm 4
Dec 12, 2022BROUSSARD BRUCE DChief Executive OfficerSale7,000$531.92$3.7MForm 4
Nov 3, 2022Diamond Susan MChief Financial OfficerSale5,623$566.25$3.2MForm 4
Nov 3, 2022BROUSSARD BRUCE DChief Executive OfficerSale9,000$566.17$5.1MForm 4
Nov 3, 2022Fleming William KevinChief Corporate Aff. OfficerSale11,157$565.61$6.3MForm 4
Nov 3, 2022Ventura Joseph CChief Legal OfficerSale3,155$565.27$1.8MForm 4
Nov 3, 2022Wheatley Timothy AlanSegment President, RetailSale22,570$566.21$12.8MForm 4
Nov 3, 2022Deshpande SamirChief Information OfficerSale7,962$565.95$4.5MForm 4
Sep 20, 2022Huval Timothy S.Chief Administrative OfficerSale7,437$505.51$3.8MForm 4
Sep 20, 2022Ventura Joseph CChief Legal OfficerSale1,226$506.78$621.3KForm 4
May 3, 2022Deshpande SamirChief Information OfficerSale3,957$434.19$1.7MForm 4

All 23 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Stakes it holds

Humana has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025Celeste M. Mellet Chief Financial Officer$900.0K$18.9M133
2025James A. RechtinPresident and Chief Executive Officer55$1.3M$18.8M133
2025Japan A. Mehta Chief Information Officer$618.8K$9.6M133
2025Michelle A. O’Hara Chief Human Resources Officer$715.4K$8.9M133
2025Sanjay K. Shetty, M.D. President, CenterWell$715.8K$7.2M133
2025Susan M. Diamond Former Chief Financial Officer$961.1K$2.4M133
2024James A. RechtinPresident and Chief Executive Officer55$1.1M$15.6M133
2024Susan M. Diamond Former Chief Financial Officer$846.2K$9.6M133
2024Sanjay K. Shetty, M.D. President, CenterWell$694.8K$6.4M133
2023Susan M. Diamond Former Chief Financial Officer$790.0K$4.7M133
2023Sanjay K. Shetty, M.D. President, CenterWell$493.3K$4.6M133

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Dodge & Cox10,940,380$4.3B2.3%−440,293
BlackRock, Inc.10,417,803$4.1B0.1%+218,748
Vanguard Capital Management LLC7,843,620$3.1B0.1%+4,858
Vanguard Portfolio Management LLC5,818,956$2.3B0.1%+10,521
State Street Corp5,457,072$2.2B0.1%+4,080
Pzena Investment Management LLC4,403,136$1.7B5.1%−1,067,846
Massachusetts Financial Services Co /ma/3,578,245$1.7B0.5%−904,125
Eagle Capital Management LLC3,846,762$1.5B4.7%+879,688
Sessa Capital IM, L.P.3,727,740$1.5B25.6%No change
Geode Capital Management, LLC3,369,757$1.3B0.1%+43,062
Jpmorgan Chase & Co3,234,637$1.3B0.1%+200,409
Fmr LLC2,913,763$1.2B0.1%+79,461
Capital International Investors2,392,826$950.5M0.2%+406,678
Goldman Sachs Group Inc2,299,889$913.6M0.1%+393,995
Naya Capital Management Uk Ltd1,833,763$728.4M43.7%+168,641
Norges Bank1,748,414$694.5M0.1%New
Invesco Ltd.1,478,788$587.4M0.0%−907,025
Charles Schwab Investment Management Inc1,370,831$544.5M0.1%+84,174
Morgan Stanley1,349,066$535.9M0.0%−98,531
Dimensional Fund Advisors LP1,122,669$445.8M0.1%−89,205
Capital Research Global Investors1,116,990$443.5M0.1%+17,151
Northern Trust Corp1,115,198$443.0M0.1%−25,002
Slate Path Capital LP1,079,930$429.0M5.9%+620,230
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC1,072,296$425.9M0.1%−21,480
Capital World Investors1,022,425$406.1M0.0%+927,924

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

18 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

DateMemberTradeAmountVs S&P sinceFiling
Mar 27, 2026Alan ArmstrongRepublican, SenateBuy$1,001 - $15,000+133.9%Report
Feb 10, 2026Julia LetlowRepublican, HouseSale$1,001 - $15,000−126.9%Report
Nov 12, 2025Gilbert Ray Cisneros, Jr.Democratic, HouseSale$1,001 - $15,000−66.8%Report
Oct 31, 2025Lisa C. McClainRepublican, HouseSale$1,001 - $15,000−42.2%Report
Oct 30, 2025Lisa C. McClainRepublican, HouseBuy$1,001 - $15,000+37.8%Report
Oct 30, 2025Lisa C. McClainRepublican, HouseSale$1,001 - $15,000−37.8%Report
Sep 25, 2025Lisa C. McClainRepublican, HouseBuy$1,001 - $15,000+52.6%Report
Aug 8, 2025Julia LetlowRepublican, HouseBuy$1,001 - $15,000+40.9%Report
Aug 5, 2025Gilbert Ray Cisneros, Jr.Democratic, HouseBuy$1,001 - $15,000+46.9%Report
Jun 24, 2025Lisa C. McClainRepublican, HouseBuy$1,001 - $15,000+53.8%Report
May 30, 2025Gilbert Ray Cisneros, Jr.Democratic, HouseSale$1,001 - $15,000−54.4%Report
May 15, 2025Robert P. Bresnahan, Jr.Republican, HouseSale$1,001 - $15,000−59.3%Report
Apr 29, 2025Gilbert Ray Cisneros, Jr.Democratic, HousePartial sale$1,001 - $15,000−27.4%Report
Feb 26, 2025Gilbert Ray Cisneros, Jr.Democratic, HouseBuy$1,001 - $15,000+39.6%Report
Feb 25, 2025Robert P. Bresnahan, Jr.Republican, HouseBuy$1,001 - $15,000+36.8%Report
Sep 4, 2024John JamesRepublican, HouseSale$1,001 - $15,000+23.7%Report
Nov 10, 2023John JamesRepublican, HouseBuy$1,001 - $15,000−87.5%Report
Mar 18, 2020Gilbert Ray Cisneros, Jr.Democratic, HouseBuy$1,001 - $15,000−146.3%Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

SEC filer profile

How Humana is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARHUMANA INC2
  • CIK0000049071
  • Employer ID (EIN)61-064753819
  • Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company19
  • Incorporated inDelaware19
  • Fiscal year endsDecember 312
  • Industry code (SIC)6324 Hospital & Medical Service Plans2
  • SEC reviewing officeOffice of Finance, Division of Corporation Finance2
  • Business address101 E. Main Street, Louisville, KY2
  • Phone50258010002
  • Shares outstanding120,061,500 as of Mar 31, 202617
  • Public float$29.2B as of Jun 30, 202519
  • AuditorPricewaterhouseCoopers LLP, Louisville, Kentucky PCAOB ID 238; it also attests to the company’s internal control over financial reporting19
  • On EDGAR sinceFeb 1, 19942
  • Filings3,469 in all: 4 (1,892), 8-K (462), 144 (309), SC 13G/A (114), 425 (103), 10-Q (98), 3 (92), 11-K (61)2
    All 49 form types

    SC 13G (41), DEF 14A (33), 424B5 (31), DEFA14A (29), 10-K (28), UPLOAD (19), FWP (17), 4/A (15), S-8 (15), CORRESP (12), ARS (11), 5 (10), 8-K/A (7), S-3ASR (7), SC 14D1/A (7), 10-K405 (5), SCHEDULE 13G/A (5), 424B3 (4), CT ORDER (4), 10-K/A (3), 8-A12B/A (3), S-3/A (3), S-8 POS (3), 10-Q/A (2), 3/A (2), DEFR14A (2), PX14A6G (2), S-3 (2), SC 13D (2), SC 13D/A (2), SCHEDULE 13G (2), 144/A (1), 424B1 (1), 424B2 (1), 6-K (1), DEFM14A (1), DEFS14A (1), POSASR (1), PRE 14A (1), PREM14A (1), SC 14D1 (1)

  • Latest filingsAnnual report (10-K) Feb 19, 2026
    Quarterly report (10-Q) Jul 29, 2026
    Proxy statement (DEF 14A) Mar 6, 2026
    Latest 8-K (8-K) Oct 13, 2026

Securities registered for trading

ClassSymbolExchange
Common stock, $0.16 2/3 par valueHUMNew York Stock Exchange

From the cover page of the 10-K filed Feb 19, 2026 (Section 12(b) of the Exchange Act).19

Risk factors and legal proceedings

The risks Humana names in Item 1A of its 10-K filed Feb 19, 2026: 16 risks under these headings, as written.19

  • Risks Relating to Our Business
  • If we fail to effectively implement our operational and strategic initiatives, including our Medicare initiatives, which are of particular importance given the concentration of our revenues in these products, our state-based contracts strategy, the growth of our CenterWell businesses, and our integrated care delivery model, our business may be materially adversely affected.
  • If we fail to properly maintain the integrity of our data, to strategically maintain existing or implement new information systems (including systems powered by or incorporating AI/ML), or to protect our proprietary rights to our systems, our business may be materially adversely affected.
  • We are involved in various legal actions and governmental and internal investigations, any of which, if resolved unfavorably to us, could result in substantial monetary damages or changes in our business practices. Increased litigation and negative publicity could increase our cost of doing business.
  • As a government contractor, we are exposed to risks that may materially adversely affect our business or our willingness or ability to participate in government health care programs.
  • Our business activities are subject to substantial government regulation. New laws or regulations, or legislative, judicial, or regulatory changes in existing laws or regulations or their manner of application could increase our cost of doing business and may have a material adverse effect on our results of operations, or cash flows.
  • New Laws or Regulations, or Future Legislative, Judicial or Regulatory Changes
  • Health Insurance Portability and Accountability Act (HIPAA) and the Health Information Technology for Economic and Clinical Health Act (HITECH Act)
  • Corporate Practice of Medicine and Other Laws
  • Anti-Kickback, Physician Self-Referral, and Other Fraud and Abuse Laws
  • State Regulation of our Products and Services
  • Any failure by us to manage acquisitions, divestitures and other significant transactions successfully may have a material adverse effect on our results of operations, financial position, and cash flows.
The other 7 risks
  • If we fail to develop and maintain satisfactory relationships with the providers of care to our members, our business may be adversely affected.
  • We face significant competition in attracting and retaining talented employees. Further, managing succession for, and retention of, key executives is critical to our success, and our failure to do so could adversely affect our businesses, operating results and/or future performance.
  • Our pharmacy solutions business is highly competitive and subjects us to regulations and distribution and supply chain risks in addition to those we face with our core health benefits businesses.
  • Changes in the prescription drug industry pricing benchmarks may adversely affect our financial performance.
  • Our ability to obtain funds from certain of our licensed subsidiaries is restricted by state insurance regulations.
  • Downgrades in our debt ratings, should they occur, may adversely affect our business, results of operations, and financial condition.
  • Volatility or disruption in the securities and credit markets, including changes in interest rates, may significantly and adversely affect the value of our investment portfolio and the investment income that we derive from this portfolio.

Legal proceedings

We are party to a variety of legal actions in the ordinary course of business, certain of which may be styled as class-action lawsuits. Among other matters, this litigation may include employment matters, claims of medical malpractice, bad faith, nonacceptance or termination of providers, anticompetitive practices, improper rate setting, provider contract rate disputes, qui tam litigation brought by individuals seeking to sue on behalf of the government, failure to disclose network discounts and various other provider arrangements, general contractual matters, intellectual property matters, and challenges to subrogation practices. For a discussion of our material legal actions, including those not in the ordinary course of business, see “Legal Proceedings and Certain Regulatory Matters” in Note 17 to the audited Consolidated Financial Statements included in Item 8. – Financial Statements and Supplementary Data. We cannot predict the outcome of these suits with certainty.

The opening of Item 3, Legal Proceedings.19

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
    Yahoo FinanceHUM quote
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
    Wikidata and SEC EDGARDavid Feinberg, Board member
  78. 78
    Wikidata and SEC EDGARBrad Smith, Board member
  79. 79
    Wikidata and SEC EDGARJorge Mesquita, Board member
  80. 80
    Wikidata and SEC EDGARMarcy Klevorn, Board member
  81. 81
    Wikidata and SEC EDGARJohn Garratt, Board member
  82. 82
  83. 83
    Wikidata and SEC EDGARRaquel C. Bono, Board member
  84. 84
  85. 85
    Wikidata and SEC EDGARKaren Katz, Board member
  86. 86
  87. 87
  88. 88
    Wikidata and SEC EDGARKurt Hilzinger, Board member
  89. 89
    Wikidata and SEC EDGARBruce Broussard, Board member
  90. 90
  91. 91
  92. 92
    Wikidata and SEC EDGARWilliam McDonald, Board member
  93. 93
  94. 94
  95. 95
  96. 96
  97. 97
    Wikidata and SEC EDGARFrank D'Amelio, Board member
  98. 98
  99. 99
  100. 100
  101. 101
    Wikidata and SEC EDGARDavid A. Jones, Jr., Board member
  102. 102
  103. 103
  104. 104
  105. 105
  106. 106
  107. 107
  108. 108
  109. 109
  110. 110
  111. 111
  112. 112
  113. 113
  114. 114
  115. 115
  116. 116
  117. 117
  118. 118
  119. 119
  120. 120
  121. 121
  122. 122
  123. 123
  124. 124
  125. 125
  126. 126
  127. 127
  128. 128
  129. 129
  130. 130
  131. 131
  132. 132
  133. 133